KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 123 filers reported holding KRYSTAL BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,085 | +4.0% | 112,800 | +5.2% | 0.07% | +9.0% |
| Q2 2023 | $12,585 | +49.4% | 107,200 | +1.9% | 0.07% | +36.7% |
| Q1 2023 | $8,422 | +1.1% | 105,200 | 0.0% | 0.05% | -5.8% |
| Q4 2022 | $8,334 | -99.9% | 105,200 | +0.3% | 0.05% | +6.1% |
| Q3 2022 | $7,312,000 | -1.4% | 104,900 | -7.1% | 0.05% | +2.1% |
| Q2 2022 | $7,413,000 | +1.3% | 112,900 | +2.6% | 0.05% | +17.1% |
| Q1 2022 | $7,319,000 | +16.2% | 110,000 | +22.2% | 0.04% | +32.3% |
| Q4 2021 | $6,296,000 | +34.0% | 90,000 | 0.0% | 0.03% | +24.0% |
| Q3 2021 | $4,699,000 | -23.2% | 90,000 | 0.0% | 0.02% | -21.9% |
| Q2 2021 | $6,120,000 | -11.7% | 90,000 | 0.0% | 0.03% | -17.9% |
| Q1 2021 | $6,934,000 | +28.4% | 90,000 | 0.0% | 0.04% | +18.2% |
| Q4 2020 | $5,400,000 | +39.4% | 90,000 | 0.0% | 0.03% | +17.9% |
| Q3 2020 | $3,874,000 | -48.0% | 90,000 | -50.0% | 0.03% | -12.5% |
| Q2 2020 | $7,456,000 | – | 180,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |